Target intelligence / Profile preview

Serum and extracellular matrix components

Molecular classification
Macromolecule, Other
01

Overview

Serum and extracellular matrix components represent a diverse assembly of proteins and macromolecules that constitute the host's systemic and local environment. This category encompasses major plasma proteins such as albumin and fibrinogen, as well as structural constituents of the extracellular matrix (ECM) like collagen, laminin, and fibronectin. These molecules are essential for maintaining tissue architecture, mediating cell signaling, and regulating physiological processes such as hemostasis and the immune response. In clinical pharmacology, these components are primarily studied for their role in plasma protein binding, which dictates the distribution and bioavailability of most systemic drugs. Additionally, many pathogens exploit these host molecules as anchors for adhesion and invasion, utilizing specialized surface proteins to facilitate colonization. While not a single molecular target, this group is a fundamental consideration in pharmacokinetic modeling and the development of anti-infective and anti-fibrotic therapies.

Other names
Host serum proteinsExtracellular matrix proteinsPlasma proteinsAdhesion ligandsECM components
02

Mechanism of action

Binding to host proteins to modulate physiological processes such as fibrinolysis and coagulation, or serving as substrates for bacterial proteases and anchors for microbial adhesion.

03

Biological functions

Cell adhesionImmune responseSignal transductionCoagulationStructural supportOther
04

Disease associations

InfectionInflammationCardiovascular diseaseCancerFibrosisOther
05

Safety considerations

Drug-drug interactions due to high plasma protein bindingImmunogenicity and allergic reactionsNon-specific binding reducing therapeutic efficacyPathogen evasion of the immune system through host protein recruitment
06

Interacting drugs

Heparin

6 more in the full profile.

07

Biomarkers

Serum albuminFibrinogenProcollagen type III amino-terminal peptide (PIIINP)C-telopeptide of type I collagen (CTX)

Beyond the preview

Go deeper on Serum and extracellular matrix components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum and extracellular matrix components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call